Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

BT2

SKU: orb1219700

Description

BT2 is a BCKDC kinase (BDK) inhibitor with an IC50 of 3.19 μM. BT2 (compound 4) is also a potent and selective Mcl-1 inhibitor with a Ki value of 59 μM. BT2 binding to BDK triggers helix movements in the N-terminal domain, resulting in the dissociation of BDK from the branched-chain α-ketoacid dehydrogenase complex (BCKDC).BT2 treatment reduces the protein levels of BDK in kidneys and heart[1]. The -fold activation of BCKDC activity in the above tissues correlates with decreased phosphorylation in heart, muscle, and kidney after the long term BT2 treatment. BT2 (20 mg/kg/day; intraperitoneal injection; daily; for 7 days; C57BL/6J male mice) treatment robustly enhances BCKDC activity in the heart (12.3-fold) compared with the vehicle-treated animals. Less activation is obtained in muscle and kidney at 3.6- and 3.8-fold, respectively.

Images & Validation

Key Properties

CAS Number34576-94-8
MW247.1
Purity>98% (HPLC)
FormulaC9H4Cl2O2S
SMILESOC(=O)c1sc2cc(Cl)ccc2c1Cl
TargetBcl-2
SolubilityDMSO:83.33 mg/mL (337.23 mM; Need ultrasonic)

Bioactivity

In Vivo
BT2 (20 mg/kg/day; intraperitoneal injection; daily; for 7 days; C57BL/6J male mice) treatment robustly enhances BCKDC activity in the heart (12.3-fold) compared with the vehicle-treated animals. Less activation is obtained in muscle and kidney at 3.6-and 3.8-fold, respectively. The-fold activation of BCKDC activity in the above tissues correlates with decreased phosphorylation in heart, muscle, and kidney after the long term BT2 treatment. BT2 treatment reduces the protein levels of BDK in kidneys and heart. Animal model: C57BL/6J male mice (8-10-week-old). Dosage: 20 mg/kg/day. Administration: Intraperitoneal injection; daily; for 1 week. Result: BCKDC activity was robustly (12.3-fold) enhanced in the heart compared with the vehicle-treated animals. Less activation was obtained in muscle and kidney at 3.6-and 3.8-fold, respectively. The protein levels of BDK in kidneys and heart were reduced to averages of 39 and 24%, respectively.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • cry1Ab Antibody (Biotin) [orb240426]

    ELISA

    Bacteria

    Rabbit

    Polyclonal

    Biotin

    100 μg, 50 μg
  • cry1Ab Antibody (FITC) [orb240427]

    Bacteria

    Rabbit

    Polyclonal

    FITC

    100 μg, 50 μg
  • cry1Ab Antibody (HRP) [orb240428]

    ELISA

    Bacteria

    Rabbit

    Polyclonal

    HRP

    100 μg, 50 μg
  • cry1Ab Antibody [orb240433]

    ELISA

    Bacteria

    Rabbit

    Polyclonal

    Unconjugated

    100 μg, 50 μg
  • cry1Ab Antibody (Biotin) [orb240434]

    ELISA

    Bacteria

    Rabbit

    Polyclonal

    Biotin

    100 μg, 50 μg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

10 mg
$ 80.00
25 mg
$ 110.00
50 mg
$ 130.00
100 mg
$ 180.00
500 mg
$ 410.00